[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity

Rhea-AI Filing Summary

Boston Scientific SVP and Chief HR Officer Miriam O'Sullivan reported several equity compensation transactions dated February 12, 2026. She acquired 961 shares of Boston Scientific common stock at $0.0000 through the exercise of restricted stock units, then had 338 shares withheld at $74.12 per share to cover tax obligations, leaving 15,420 directly held shares plus 1,731 held indirectly by her spouse.

On the derivative side, she exercised 961 restricted stock units, ending with 1,924 restricted stock units directly owned. She also received a new grant of 4,722 restricted stock units and a stock option award for 11,143 shares. The restricted stock units and options vest in four equal annual installments beginning on February 12, 2027, with the earlier RSU grant delivering shares in four equal installments starting February 12, 2025.

Insider Trade Summary

961 shares exercised/converted

Mixed 6 txns

Insider O'Sullivan Miriam

Role SVP, Chief HR Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	961	$0.00	--
Grant/Award	Restricted Stock Units	4,722	$0.00	--
Grant/Award	Stock Option (Right to Buy)	11,143	$0.00	--
Exercise	Common Stock	961	$0.00	--
Tax Withholding	Common Stock	338	$74.12	$25K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 1,924 shares (Direct); Stock Option (Right to Buy) — 11,143 shares (Direct); Common Stock — 15,758 shares (Direct); Common Stock — 1,731 shares (Indirect, By Spouse)

Footnotes (1)

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Sullivan Miriam

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MA 01752-1234

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		M		961	A	$0.0000(1)	15,758	D
Common Stock	02/12/2026		F		338	D	$74.12	15,420	D
Common Stock								1,731	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/12/2026		M			961	(2)	02/12/2028(2)	Common Stock	961	$0.0000	1,924	D
Restricted Stock Units	(1)	02/12/2026		A		4,722		(3)	02/12/2030(3)	Common Stock	4,722	$0.0000	4,722	D
Stock Option (Right to Buy)	$74.12	02/12/2026		A		11,143		(4)	02/12/2036	Common Stock	11,143	$0.0000	11,143	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

4. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.